Delphin-Rittmon Nominated to Serve as Assistant Secretary for Mental Health and Substance Use in Biden Administration
Miriam Delphin-Rittmon, PhD, Associate Professor Adjunct of Psychiatry at Yale School of Medicine and Commissioner of the Connecticut Department of Mental Health and Addiction Services (DMHAS), has been nominated by President Joe Biden to serve as Assistant Secretary for Mental Health and Substance Use with the U.S. Department of Health and Human Services.
Leffert Is Named Chair of Anesthesiology at Yale School of Medicine
Lisa R. Leffert, MD, will be the new chair of the Department of Anesthesiology at Yale School of Medicine and chief of Anesthesiology at Yale New Haven Hospital and Bridgeport Hospital, effective August 16, 2021. Leffert is currently associate professor of anesthesia at Harvard Medical School and chief of the Division of Obstetric Anesthesia at Massachusetts General Hospital.
Yale School of Medicine Is in the Top Ten in Latest U.S. News Rankings
The latest rankings by U.S. News & World Report place Yale School of Medicine at number 10 among the best medical schools in the nation for research, based on measures that include strong NIH funding and reputation among professional peers.
Keeping Yale's COVID-19 Treatment Guidelines Up to Date
For the past year, experts across various disciplines have studied and carefully considered each new piece of evidence about treatment strategies for COVID-19 and translated it into standardized guidelines for Yale School of Medicine and Yale New Haven Health System clinicians
Immunotherapy Drug Delays Onset of Type 1 Diabetes in At-risk Group
The drug, developed by biotechnology company Provention and evaluated by Yale researchers, has been awarded breakthrough status by the U.S. Food and Drug Administration and could be approved for general use by summer.Source: YaleNews
Chênevert Family Brain Tumor Center Launched at Yale
Yale School of Medicine announces a gift to establish the Chênevert Family Brain Tumor Center at Yale Cancer Center. The Chênevert Family Brain Tumor Center will be a leading center in Neuro-Oncology research worldwide, bringing ground-breaking solutions and hope to patients with brain tumors.
Yale Targets COVID-19 with Innovative Computational Design Methods
Yale scientists have developed a new class of antiviral agents that shows promise for creating COVID-19 therapeutics — exhibiting particular effectiveness when used in tandem with the drug remdesivir, another antiviral medication approved for use against the virus.Source: YaleNews